{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:35:09Z","timestamp":1795120509489,"version":"4.10.3"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17209225"],"award-info":[{"award-number":["17209225"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","award":["2407102490"],"award-info":[{"award-number":["2407102490"]}],"id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["82370332, 82570390"],"award-info":[{"award-number":["82370332, 82570390"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68956-6","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:45:36Z","timestamp":1770072336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["AI-based multiomics profiling reveals complementary omics contributions to personalized prediction of cardiovascular disease"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-4983","authenticated-orcid":false,"given":"Yan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-7686","authenticated-orcid":false,"given":"Kelvin K. F.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6819-0686","authenticated-orcid":false,"given":"Qingpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"68956_CR1","unstructured":"Mensah, G. A., Fuster, V., Murray, C. J. L., Roth, G. A. & Global Burden of Cardiovascular Diseases and Risks Collaborators. Global burden of cardiovascular diseases and risks, 1990\u20132022. J. Am. Coll. Cardiol. 82, 2350\u20132473 (2023)."},{"key":"68956_CR2","doi-asserted-by":"publisher","unstructured":"Chong, B. et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur. J. Prev. Cardiol. zwae281 (2024) https:\/\/doi.org\/10.1093\/eurjpc\/zwae281.","DOI":"10.1093\/eurjpc\/zwae281"},{"key":"68956_CR3","unstructured":"World Health Organization. HEARTS: Technical Package For Cardiovascular Disease Management in Primary Health Care: Risk-based CVD Management (World Health Organization, 2020)."},{"key":"68956_CR4","first-page":"e596","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett, D. K. et al. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140, e596\u2013e646 (2019).","journal-title":"Circulation"},{"key":"68956_CR5","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren, F. L. J. et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 42, 3227\u20133337 (2021).","journal-title":"Eur. Heart J."},{"key":"68956_CR6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/01.ATV.0000075081.51227.86","volume":"23","author":"CF Sing","year":"2003","unstructured":"Sing, C. F., Steng\u00e5rd, J. H. & Kardia, S. L. R. Genes, environment, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 23, 1190\u20131196 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68956_CR7","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff","year":"2014","unstructured":"Goff, D. C. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk. Circulation 129, S49\u2013S73 (2014).","journal-title":"Circulation"},{"key":"68956_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-3011","volume":"169","author":"S Yadlowsky","year":"2018","unstructured":"Yadlowsky, S. et al. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann. Intern. Med. 169, 20\u201329 (2018).","journal-title":"Ann. Intern. Med."},{"key":"68956_CR9","doi-asserted-by":"crossref","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42, 2439\u20132454 (2021).","DOI":"10.1093\/eurheartj\/ehab309"},{"key":"68956_CR10","doi-asserted-by":"publisher","first-page":"e3318","DOI":"10.1136\/bmj.e3318","volume":"344","author":"GCM Siontis","year":"2012","unstructured":"Siontis, G. C. M., Tzoulaki, I., Siontis, K. C. & Ioannidis, J. P. A. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 344, e3318 (2012).","journal-title":"BMJ"},{"key":"68956_CR11","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.124.070081","volume":"150","author":"FR Giugni","year":"2024","unstructured":"Giugni, F. R., Berry, J. D., Khera, A., Shah, A. M. & de Lemos, J. A. Precision medicine for cardiovascular prevention and population health: a bridge too far?. Circulation 150, 1720\u20131731 (2024).","journal-title":"Circulation"},{"key":"68956_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jama.2019.22241","volume":"323","author":"J Elliott","year":"2020","unstructured":"Elliott, J. et al. Predictive accuracy of a polygenic risk score\u2013enhanced prediction model vs. a clinical risk score for coronary artery disease. JAMA 323, 636\u2013645 (2020).","journal-title":"JAMA"},{"key":"68956_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1001\/jamacardio.2022.4466","volume":"8","author":"NA Marston","year":"2023","unstructured":"Marston, N. A. et al. Predictive utility of a coronary artery disease polygenic risk score in primary prevention. JAMA Cardiol. 8, 130\u2013137 (2023).","journal-title":"JAMA Cardiol."},{"key":"68956_CR14","doi-asserted-by":"publisher","unstructured":"Li, L., Pang, S., Starnecker, F., Mueller-Myhsok, B. & Schunkert, H. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease. Eur. Heart J. ehae048 https:\/\/doi.org\/10.1093\/eurheartj\/ehae048 (2024).","DOI":"10.1093\/eurheartj\/ehae048"},{"key":"68956_CR15","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/eurheartj\/ehad161","volume":"44","author":"NS Nurmohamed","year":"2023","unstructured":"Nurmohamed, N. S. et al. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur. Heart J. 44, 1594\u20131607 (2023).","journal-title":"Eur. Heart J."},{"key":"68956_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50125-2","volume":"15","author":"J Lv","year":"2024","unstructured":"Lv, J. et al. Plasma metabolomics reveals the shared and distinct metabolic disturbances associated with cardiovascular events in coronary artery disease. Nat. Commun. 15, 5729 (2024).","journal-title":"Nat. Commun."},{"key":"68956_CR17","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","volume":"28","author":"T Buergel","year":"2022","unstructured":"Buergel, T. et al. Metabolomic profiles predict individual multidisease outcomes. Nat. Med. 28, 2309\u20132320 (2022).","journal-title":"Nat. Med."},{"key":"68956_CR18","doi-asserted-by":"publisher","unstructured":"Ritchie, S. C. et al. Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction. Eur. Heart J. ehaf947, https:\/\/doi.org\/10.1093\/eurheartj\/ehaf947 (2025).","DOI":"10.1093\/eurheartj\/ehaf947"},{"key":"68956_CR19","doi-asserted-by":"crossref","unstructured":"Nightingale Health Biobank Collaborative Group. Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks. Nat. Commun. 15, 10092 (2024).","DOI":"10.1038\/s41467-024-54357-0"},{"key":"68956_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jama.2023.13258","volume":"330","author":"H Helgason","year":"2023","unstructured":"Helgason, H. et al. Evaluation of large-scale proteomics for prediction of cardiovascular events. JAMA 330, 725\u2013735 (2023).","journal-title":"JAMA"},{"key":"68956_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41588-024-01898-1","volume":"56","author":"M Garg","year":"2024","unstructured":"Garg, M. et al. Disease prediction with multi-omics and biomarkers empowers case-control genetic discoveries in the UK Biobank. Nat. Genet. 56, 1821\u20131831 (2024).","journal-title":"Nat. Genet."},{"key":"68956_CR22","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1093\/eurheartj\/ehaa648","volume":"41","author":"RM Hoogeveen","year":"2020","unstructured":"Hoogeveen, R. M. et al. Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention. Eur. Heart J. 41, 3998\u20134007 (2020).","journal-title":"Eur. Heart J."},{"key":"68956_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jacc.2023.11.021","volume":"83","author":"K Shelbaya","year":"2024","unstructured":"Shelbaya, K. et al. Large-scale proteomics identifies novel biomarkers and circulating risk factors for aortic stenosis. J. Am. Coll. Cardiol. 83, 577\u2013591 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68956_CR24","doi-asserted-by":"publisher","unstructured":"Royer, P. et al. Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular disease. Eur. J. Prev. Cardiol. zwae124 (2024) https:\/\/doi.org\/10.1093\/eurjpc\/zwae124.","DOI":"10.1093\/eurjpc\/zwae124"},{"key":"68956_CR25","doi-asserted-by":"publisher","unstructured":"Schuermans, A. et al. Integrative proteomic analyses across common cardiac diseases yield mechanistic insights and enhanced prediction. Nat. Cardiovasc. Res. 1\u201315 https:\/\/doi.org\/10.1038\/s44161-024-00567-0 (2024).","DOI":"10.1038\/s44161-024-00567-0"},{"key":"68956_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43575-7","volume":"14","author":"J You","year":"2023","unstructured":"You, J. et al. Plasma proteomic profiles predict individual future health risk. Nat. Commun. 14, 7817 (2023).","journal-title":"Nat. Commun."},{"key":"68956_CR27","doi-asserted-by":"publisher","unstructured":"Carrasco-Zanini, J. et al. Proteomic signatures improve risk prediction for common and rare diseases. Nat. Med. 1\u201310 https:\/\/doi.org\/10.1038\/s41591-024-03142-z (2024).","DOI":"10.1038\/s41591-024-03142-z"},{"key":"68956_CR28","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1016\/S2589-7500(24)00087-6","volume":"6","author":"J Carrasco-Zanini","year":"2024","unstructured":"Carrasco-Zanini, J. et al. Proteomic prediction of diverse incident diseases: a machine learning-guided biomarker discovery study using data from a prospective cohort study. Lancet Digit. Health 6, e470\u2013e479 (2024).","journal-title":"Lancet Digit. Health"},{"key":"68956_CR29","doi-asserted-by":"publisher","unstructured":"Gadd, D. A. et al. Blood protein assessment of leading incident diseases and mortality in the UK Biobank. Nat. Aging 1\u201310 (2024) https:\/\/doi.org\/10.1038\/s43587-024-00655-7.","DOI":"10.1038\/s43587-024-00655-7"},{"key":"68956_CR30","doi-asserted-by":"publisher","unstructured":"Ho, F. K. et al. A proteomics-based approach for prediction of different cardiovascular diseases and dementia. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.124.070454 (2024).","DOI":"10.1161\/CIRCULATIONAHA.124.070454"},{"key":"68956_CR31","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/heartjnl-2024-324274","volume":"110","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. Enhanced prediction of atrial fibrillation risk using proteomic markers: a comparative analysis with clinical and polygenic risk scores. Heart 110, 1270\u20131276 (2024).","journal-title":"Heart"},{"key":"68956_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s44161-024-00422-2","volume":"3","author":"S Gustafsson","year":"2024","unstructured":"Gustafsson, S. et al. Markers of imminent myocardial infarction. Nat. Cardiovasc. Res. 3, 130\u2013139 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"68956_CR33","doi-asserted-by":"publisher","unstructured":"Mazidi, M. et al. Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults. Eur. J. Epidemiol. https:\/\/doi.org\/10.1007\/s10654-024-01168-8 (2024).","DOI":"10.1007\/s10654-024-01168-8"},{"key":"68956_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36231-7","volume":"14","author":"H Julkunen","year":"2023","unstructured":"Julkunen, H. et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat. Commun. 14, 604 (2023).","journal-title":"Nat. Commun."},{"key":"68956_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.117877","volume":"557","author":"M Gong","year":"2024","unstructured":"Gong, M. et al. Proteomics in Cardiovascular disease. Clin. Chim. Acta 557, 117877 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"68956_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/14789450.2017.1274653","volume":"14","author":"M Mokou","year":"2017","unstructured":"Mokou, M., Lygirou, V., Vlahou, A. & Mischak, H. Proteomics in cardiovascular disease: recent progress and clinical implication and implementation. Expert Rev. Proteom. 14, 117\u2013136 (2017).","journal-title":"Expert Rev. Proteom."},{"key":"68956_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00125-023-06027-x","volume":"67","author":"J Carrasco-Zanini","year":"2024","unstructured":"Carrasco-Zanini, J. et al. Multi-omic prediction of incident type 2 diabetes. Diabetologia 67, 102\u2013112 (2024).","journal-title":"Diabetologia"},{"key":"68956_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46663-4","volume":"15","author":"RL Nielsen","year":"2024","unstructured":"Nielsen, R. L. et al. Data-driven identification of predictive risk biomarkers for subgroups of osteoarthritis using interpretable machine learning. Nat. Commun. 15, 2817 (2024).","journal-title":"Nat. Commun."},{"key":"68956_CR39","doi-asserted-by":"publisher","unstructured":"Argentieri, M. A. et al. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. Nat. Med. 1\u201311 https:\/\/doi.org\/10.1038\/s41591-024-03164-7 (2024).","DOI":"10.1038\/s41591-024-03164-7"},{"key":"68956_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52310-9","volume":"15","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank. Nat. Commun. 15, 8081 (2024).","journal-title":"Nat. Commun."},{"key":"68956_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61891-y","volume":"16","author":"H Julkunen","year":"2025","unstructured":"Julkunen, H. & Rousu, J. Comprehensive interaction modeling with machine learning improves prediction of disease risk in the UK Biobank. Nat. Commun. 16, 6620 (2025).","journal-title":"Nat. Commun."},{"key":"68956_CR42","doi-asserted-by":"publisher","unstructured":"Efthimiou, O. et al. Developing clinical prediction models: a step-by-step guide. BMJ e078276 https:\/\/doi.org\/10.1136\/bmj-2023-078276 (2024).","DOI":"10.1136\/bmj-2023-078276"},{"key":"68956_CR43","doi-asserted-by":"publisher","first-page":"i6","DOI":"10.1136\/bmj.i6","volume":"352","author":"AJ Vickers","year":"2016","unstructured":"Vickers, A. J., Calster, B. V. & Steyerberg, E. W. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ 352, i6 (2016).","journal-title":"BMJ"},{"key":"68956_CR44","doi-asserted-by":"publisher","first-page":"308","DOI":"10.21037\/atm.2018.07.02","volume":"6","author":"Z Zhang","year":"2018","unstructured":"Zhang, Z. et al. Decision curve analysis: a technical note. Ann. Transl. Med. 6, 308 (2018).","journal-title":"Ann. Transl. Med."},{"key":"68956_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin, Y., Seldin, M. & Lusis, A. Multi-omics approaches to disease. Genome Biol. 18, 1\u201315 (2017).","journal-title":"Genome Biol."},{"key":"68956_CR46","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/ATVBAHA.124.321282","volume":"44","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. Integrative metabolomics differentiate coronary artery disease, peripheral artery disease, and venous thromboembolism risks. Arterioscler. Thromb. Vasc. Biol. 44, 2108\u20132117 (2024).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68956_CR47","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/j.jacc.2016.10.001","volume":"68","author":"PM McKie","year":"2016","unstructured":"McKie, P. M. & Burnett, J. C. NT-proBNP: the gold standard biomarker in heart failure. J. Am. Coll. Cardiol. 68, 2437\u20132439 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"68956_CR48","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","volume":"35","author":"M Volpe","year":"2014","unstructured":"Volpe, M., Rubattu, S. & Burnett, J. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur. Heart J. 35, 419\u2013425 (2014).","journal-title":"Eur. Heart J."},{"key":"68956_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/01.STR.28.3.557","volume":"28","author":"SG Wannamethee","year":"1997","unstructured":"Wannamethee, S. G., Shaper, A. G. & Perry, I. J. Serum creatinine concentration and risk of cardiovascular disease. Stroke 28, 557\u2013563 (1997).","journal-title":"Stroke"},{"key":"68956_CR50","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/ATVBAHA.119.313681","volume":"40","author":"A Ronit","year":"2020","unstructured":"Ronit, A. et al. Plasma albumin and incident cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 40, 473\u2013482 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68956_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1321-6","volume":"15","author":"MA Connelly","year":"2017","unstructured":"Connelly, M. A., Otvos, J. D., Shalaurova, I., Playford, M. P. & Mehta, N. N. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J. Transl. Med. 15, 219 (2017).","journal-title":"J. Transl. Med."},{"key":"68956_CR52","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.013131","volume":"9","author":"MC Borges","year":"2020","unstructured":"Borges, M. C. et al. Circulating fatty acids and risk of coronary heart disease and stroke: individual participant data meta-analysis in up to 16 126 participants. J. Am. Heart Assoc. 9, e013131 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"68956_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04580-y","volume":"21","author":"S Hu","year":"2023","unstructured":"Hu, S. et al. Causal relationships of circulating amino acids with cardiovascular disease: a trans-ancestry Mendelian randomization analysis. J. Transl. Med. 21, 699 (2023).","journal-title":"J. Transl. Med."},{"key":"68956_CR54","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg, H. N. et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European Atherosclerosis Society. Eur. Heart J. 42, 4791\u20134806 (2021).","journal-title":"Eur. Heart J."},{"key":"68956_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","volume":"63","author":"KC Wollert","year":"2017","unstructured":"Wollert, K. C., Kempf, T. & Wallentin, L. Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin. Chem. 63, 140\u2013151 (2017).","journal-title":"Clin. Chem."},{"key":"68956_CR56","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/eurheartj\/ehac577","volume":"44","author":"ET Kato","year":"2023","unstructured":"Kato, E. T. et al. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. Eur. Heart J. 44, 293\u2013300 (2023).","journal-title":"Eur. Heart J."},{"key":"68956_CR57","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/ATVBAHA.115.305631","volume":"35","author":"I Goncalves","year":"2015","unstructured":"Goncalves, I. et al. Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 35, 1723\u20131731 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"68956_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead056","volume":"3","author":"S Yuan","year":"2023","unstructured":"Yuan, S. et al. Circulating proteins and peripheral artery disease risk: observational and Mendelian randomization analyses. Eur. Heart J. Open 3, oead056 (2023).","journal-title":"Eur. Heart J. Open"},{"key":"68956_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.thromres.2015.12.020","volume":"138","author":"L Kong","year":"2016","unstructured":"Kong, L. et al. Downregulation of let-7e-5p contributes to endothelial progenitor cell dysfunction in deep vein thrombosis via targeting FASLG. Thromb. Res. 138, 30\u201336 (2016).","journal-title":"Thromb. Res."},{"key":"68956_CR60","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","volume":"20","author":"M Khalil","year":"2024","unstructured":"Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders - towards clinical application. Nat. Rev. Neurol. 20, 269\u2013287 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"68956_CR61","doi-asserted-by":"publisher","unstructured":"Park, S. et al. Hypoxia-mediated CRIP2 activation via NICD1 translocation regulates glycolysis and cell death. Genes Dis. 101704, https:\/\/doi.org\/10.1016\/j.gendis.2025.101704 (2025).","DOI":"10.1016\/j.gendis.2025.101704"},{"key":"68956_CR62","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.bbamem.2008.10.029","volume":"1788","author":"E Hughes","year":"2009","unstructured":"Hughes, E., Clayton, J. C. & Middleton, D. A. Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: a new role for phospholipids in the regulation of cardiac calcium cycling?. Biochim. Biophys. Acta 1788, 559\u2013566 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"68956_CR63","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41569-022-00717-6","volume":"19","author":"M Abdelsayed","year":"2022","unstructured":"Abdelsayed, M., Kort, E. J., Jovinge, S. & Mercola, M. Repurposing drugs to treat cardiovascular disease in the era of precision medicine. Nat. Rev. Cardiol. 19, 751\u2013764 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"68956_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"68956_CR65","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"68956_CR66","unstructured":"UK Biobank. Data Providers and Dates of Data Availability https:\/\/biobank.ndph.ox.ac.uk\/ukb\/exinfo.cgi?src=Data_providers_and_dates."},{"key":"68956_CR67","doi-asserted-by":"publisher","first-page":"818574","DOI":"10.3389\/fgene.2022.818574","volume":"13","author":"JA Collister","year":"2022","unstructured":"Collister, J. A., Liu, X. & Clifton, L. Calculating Polygenic Risk Scores (PRS) in UK Biobank: a practical guide for epidemiologists. Front. Genet. 13, 818574 (2022).","journal-title":"Front. Genet."},{"key":"68956_CR68","unstructured":"Pilling, L. ukbrapR: R Functions to Use in the UK Biobank Research Analysis Platform (RAP) https:\/\/lcpilling.github.io\/ukbrapR, https:\/\/github.com\/lcpilling\/ukbrapR (2025)."},{"key":"68956_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/STROKEAHA.123.044284","volume":"55","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Genetic susceptibility modifies relationships between air pollutants and stroke risk: a Large Cohort Study. Stroke 55, 113\u2013121 (2024).","journal-title":"Stroke"},{"key":"68956_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39253-3","volume":"14","author":"D Rasooly","year":"2023","unstructured":"Rasooly, D. et al. Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure. Nat. Commun. 14, 3826 (2023).","journal-title":"Nat. Commun."},{"key":"68956_CR71","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302708120","volume":"120","author":"Y Ma","year":"2023","unstructured":"Ma, Y. et al. Air pollution, genetic susceptibility, and the risk of atrial fibrillation: a large prospective cohort study. Proc. Natl. Acad. Sci. USA 120, e2302708120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68956_CR72","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","volume":"25","author":"D Klarin","year":"2019","unstructured":"Klarin, D. et al. Genome-wide Association Study of peripheral artery disease in the Million Veteran Program. Nat. Med. 25, 1274\u20131279 (2019).","journal-title":"Nat. Med."},{"key":"68956_CR73","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2337\/dc23-1503","volume":"47","author":"K Zhu","year":"2024","unstructured":"Zhu, K. et al. Modifiable lifestyle factors, genetic risk, and incident peripheral artery disease among individuals with type 2 diabetes: a prospective study. Diabetes Care 47, 435\u2013443 (2024).","journal-title":"Diabetes Care"},{"key":"68956_CR74","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P W\u00fcrtz","year":"2017","unstructured":"W\u00fcrtz, P. et al. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies. Am. J. Epidemiol. 186, 1084\u20131096 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"68956_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-023-01949-y","volume":"10","author":"SC Ritchie","year":"2023","unstructured":"Ritchie, S. C. et al. Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants. Sci. Data 10, 64 (2023).","journal-title":"Sci. Data"},{"key":"68956_CR76","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"68956_CR77","doi-asserted-by":"crossref","unstructured":"Akiba, T., Sano, S., Yanase, T., Ohta, T. & Koyama, M. Optuna: a next-generation hyperparameter optimization framework. In Proc. of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining 2623\u20132631 (Association for Computing Machinery, 2019).","DOI":"10.1145\/3292500.3330701"},{"key":"68956_CR78","unstructured":"Paszke, A. et al. PyTorch: an imperative style, high-performance deep learning library. In Proc. of the 33rd International Conference on Neural Information Processing Systems 8026\u20138037 (Curran Associates Inc., 2019)."},{"key":"68956_CR79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"68956_CR80","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon, C. Lifelines: survival analysis in Python. J. Open Source Softw. 4, 1317 (2019).","journal-title":"J. Open Source Softw."},{"key":"68956_CR81","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","volume":"34","author":"KF Kerr","year":"2016","unstructured":"Kerr, K. F., Brown, M. D., Zhu, K. & Janes, H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J. Clin. Oncol. 34, 2534\u20132540 (2016).","journal-title":"J. Clin. Oncol."},{"key":"68956_CR82","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.18632\/aging.101837","volume":"11","author":"BF Darst","year":"2019","unstructured":"Darst, B. F., Koscik, R. L., Hogan, K. J., Johnson, S. C. & Engelman, C. D. Longitudinal plasma metabolomics of aging and sex. Aging (Albany, NY) 11, 1262\u20131282 (2019).","journal-title":"Aging (Albany, NY)"},{"key":"68956_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10654-014-9910-7","volume":"29","author":"E Altmaier","year":"2014","unstructured":"Altmaier, E. et al. Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur. J. Epidemiol. 29, 325\u2013336 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"68956_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23860-y","volume":"8","author":"S Enroth","year":"2018","unstructured":"Enroth, S. et al. Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases. Sci. Rep. 8, 5531 (2018).","journal-title":"Sci. Rep."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68956-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68956-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:02:59Z","timestamp":1772812979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68956-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68956"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68956-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6139124\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2269"}}